Clinical Trial Update: Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and efficacy of intrathecal injection of RJK002 in patients with Amyotrophic Lateral Sclerosis; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• RJK002

Snippet

Sponsor: RJK Biopharma Ltd | Conditions: Amyotrophic Lateral Sclerosis Als | Phase 1 | Status: ACTIVE_NOT_RECRUITING